187 related articles for article (PubMed ID: 27502272)
1. Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records.
Cozzi GD; Samuel JM; Fromal JT; Keene S; Crispens MA; Khabele D; Beeghly-Fadiel A
BMC Cancer; 2016 Aug; 16():612. PubMed ID: 27502272
[TBL] [Abstract][Full Text] [Related]
2. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
Chi DS; Zivanovic O; Palayekar MJ; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Leitao MM; Brown CL; Barakat RR
Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of thrombocytosis in ovarian cancer.
Słabuszewska-Jóźwiak A; Dmoch-Gajzlerska E; Kozakiewicz B; Jakiel G
Ann Agric Environ Med; 2015; 22(4):731-5. PubMed ID: 26706987
[TBL] [Abstract][Full Text] [Related]
4. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival.
Abu-Rustum NR; Richard S; Wilton A; Lev G; Sonoda Y; Hensley ML; Gemignani M; Barakat RR; Chi DS
Gynecol Oncol; 2005 Nov; 99(2):320-6. PubMed ID: 16061278
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer.
Ma X; Wang Y; Sheng H; Tian W; Qi Z; Teng F; Xue F
J Obstet Gynaecol Res; 2014 Jan; 40(1):178-83. PubMed ID: 24102732
[TBL] [Abstract][Full Text] [Related]
6. The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer.
Lee M; Kim SW; Nam EJ; Yim GW; Kim S; Kim YT
Gynecol Oncol; 2011 Aug; 122(2):238-41. PubMed ID: 21531448
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
[TBL] [Abstract][Full Text] [Related]
8. Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
du Bois A; Kristensen G; Ray-Coquard I; Reuss A; Pignata S; Colombo N; Denison U; Vergote I; Del Campo JM; Ottevanger P; Heubner M; Minarik T; Sevin E; de Gregorio N; Bidziński M; Pfisterer J; Malander S; Hilpert F; Mirza MR; Scambia G; Meier W; Nicoletto MO; Bjørge L; Lortholary A; Sailer MO; Merger M; Harter P;
Lancet Oncol; 2016 Jan; 17(1):78-89. PubMed ID: 26590673
[TBL] [Abstract][Full Text] [Related]
9. Thrombocytosis in advanced epithelial ovarian cancer.
Soonthornthum T; Suraseraneewong V; Kengsakol K; Wijaithum K; Kasemsan P; Prommatt S
J Med Assoc Thai; 2007 Aug; 90(8):1495-500. PubMed ID: 17926975
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of pretreatment thrombocytosis in epithelial ovarian cancer.
Okunade KS; Dawodu O; Adenekan M; Nwogu CM; Awofeso O; Ugwu AO; Salako O; John-Olabode S; Olowoselu OF; Anorlu RI
Niger J Clin Pract; 2020 Aug; 23(8):1141-1147. PubMed ID: 32788493
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in chinese women with epithelial ovarian cancer.
Chen Y; Zhang L; Liu WX; Liu XY
Asian Pac J Cancer Prev; 2015; 16(3):933-9. PubMed ID: 25735385
[TBL] [Abstract][Full Text] [Related]
12. Utility of peritoneal washing cytology in staging and prognosis of ovarian and fallopian tube neoplasms: a 10-year retrospective analysis.
Davidson W; Madan R; O'Neil M; Tawfik OW; Fan F
Ann Diagn Pathol; 2016 Jun; 22():54-7. PubMed ID: 27180061
[TBL] [Abstract][Full Text] [Related]
13. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.
Esselen KM; Rodriguez N; Growdon W; Krasner C; Horowitz NS; Campos S
Gynecol Oncol; 2012 Oct; 127(1):51-4. PubMed ID: 22659193
[TBL] [Abstract][Full Text] [Related]
14. Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer.
Rizzuto I; Stavraka C; Chatterjee J; Borley J; Hopkins TG; Gabra H; Ghaem-Maghami S; Huson L; Blagden SP
Int J Gynecol Cancer; 2015 Mar; 25(3):416-22. PubMed ID: 25647256
[TBL] [Abstract][Full Text] [Related]
15. The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors.
Gungor T; Kanat-Pektas M; Sucak A; Mollamahmutoglu L
Arch Gynecol Obstet; 2009 Jan; 279(1):53-6. PubMed ID: 18470520
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer.
Allensworth SK; Langstraat CL; Martin JR; Lemens MA; McGree ME; Weaver AL; Dowdy SC; Podratz KC; Bakkum-Gamez JN
Gynecol Oncol; 2013 Sep; 130(3):499-504. PubMed ID: 23747328
[TBL] [Abstract][Full Text] [Related]
17. Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers.
Krill LS; Ueda SM; Gerardi M; Bristow RE
Gynecol Oncol; 2011 Feb; 120(2):220-3. PubMed ID: 21145096
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of Increased Perioperative Platelet Count in Gastric Cancer Patients.
Oh SE; Seo JE; An JY; Lee JH; Sohn TS; Bae JM; Kim S; Choi MG
J Surg Res; 2019 Oct; 242():296-303. PubMed ID: 31125843
[TBL] [Abstract][Full Text] [Related]
19. Does significant medical comorbidity negate the benefit of up-front cytoreduction in advanced ovarian cancer?
Ferriss JS; Ring K; King ER; Courtney-Brooks M; Duska LR; Taylor PT
Int J Gynecol Cancer; 2012 Jun; 22(5):762-9. PubMed ID: 22426409
[TBL] [Abstract][Full Text] [Related]
20. Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma.
Moschini M; Suardi N; Pellucchi F; Rocchini L; La Croce G; Capitanio U; Briganti A; Damiano R; Montorsi F; Colombo R
Anticancer Res; 2014 Jun; 34(6):3225-30. PubMed ID: 24922698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]